Association of expression of MRP1, BCRP, LRP and ERCC1 with outcome of patients with locally advanced non-small cell lung cancer who received neoadjuvant chemotherapy
作者： Jian Li , Zhen-Nan Li , Li-Chao Yu , Qian-Lei Bao , Jian-Rong Wu
DOI: 10.1016/J.LUNGCAN.2009.09.013
关键词: Chemotherapy 、 Medicine 、 ERCC1 、 Internal medicine 、 Oncology 、 Gene expression 、 Abcg2 、 Pathology 、 Respiratory disease 、 Cancer 、 Cisplatin 、 Lung cancer 、 Cancer research 、 Pulmonary and Respiratory Medicine
摘要: … full cycles of neoadjuvant cisplatin-based chemotherapy and achieved surgical resection. Patients with therapy … us to choose molecular-based personalized neoadjuvant chemotherapy. …
elsevier.com
sci-hub.se 参考文章(29)
Yu Jj, Reed E, Li Q, Yunmbam Mk, Slavsky D, Cross Cl, Bostick-Bruton F, Mu C, Association between the level of ERCC-1 expression and the repair of cisplatin-induced DNA damage in human ovarian cancer cells. Anticancer Research. ,vol. 20, pp. 645- 652 ,(2000)
A. Haimeur, G. Conseil, R. Deeley, S. Cole, (Section A: Molecular, Structural, and Cellular Biology of Drug Transporters) The MRP-Related and BCRP / ABCG2 Multidrug Resistance Proteins: Biology, Substrate Specificity and Regulation Current Drug Metabolism. ,vol. 5, pp. 21- 53 ,(2004) , 10.2174/1389200043489199
Shimeru Kamihira, Katsumi Nakatomi, Junji Tsurutani, Kazuyuki Sugahara, Mikio Oka, Yoichi Nakamura, Hiroshi Soda, Ken Shiozawa, Yasuaki Yamada, Takeshi Kitazaki, Seiji Doi, Shigeru Kohno, Shigeru Kawabata, Expression and functional analyses of breast cancer resistance protein in lung cancer. Clinical Cancer Research. ,vol. 9, pp. 3052- 3057 ,(2003)
E. Reed, Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapy. Cancer Treatment Reviews. ,vol. 24, pp. 331- 344 ,(1998) , 10.1016/S0305-7372(98)90056-1
Martin Filipits, Vincent Haddad, Katharina Schmid, Anh Huynh, Ariane Dunant, Fabrice André, Elisabeth Brambilla, Rolf Stahel, Jean-Pierre Pignon, Jean-Charles Soria, Helmut H Popper, Thierry Le Chevalier, Robert Pirker, None, Multidrug Resistance Proteins Do Not Predict Benefit of Adjuvant Chemotherapy in Patients with Completely Resected Non–Small Cell Lung Cancer: International Adjuvant Lung Cancer Trial Biologic Program Clinical Cancer Research. ,vol. 13, pp. 3892- 3898 ,(2007) , 10.1158/1078-0432.CCR-06-2446
Paul A. Bunn, James Mault, Karen Kelly, Adjuvant and Neoadjuvant Chemotherapy for Non-Small Cell Lung Cancer: A Time for Reassessment? Chest. ,vol. 117, pp. 1- 9 ,(2000) , 10.1378/CHEST.117.4_SUPPL_1.119S
M Volm, R Koomägi, J Mattern, T Efferth, Protein expression profiles indicative for drug resistance of non-small cell lung cancer. British Journal of Cancer. ,vol. 87, pp. 251- 257 ,(2002) , 10.1038/SJ.BJC.6600463
Clifton F. Mountain, Revisions in the International System for Staging Lung Cancer Chest. ,vol. 111, pp. 1710- 1717 ,(1997) , 10.1378/CHEST.111.6.1710
Ken A Olaussen, Ariane Dunant, Pierre Fouret, Elisabeth Brambilla, Fabrice André, Vincent Haddad, Estelle Taranchon, Martin Filipits, Robert Pirker, Helmut H Popper, Rolf Stahel, Laure Sabatier, Jean-Pierre Pignon, Thomas Tursz, Thierry Le Chevalier, Jean-Charles Soria, None, DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy. The New England Journal of Medicine. ,vol. 355, pp. 983- 991 ,(2006) , 10.1056/NEJMOA060570
Kazuya Endo, Yoshihiko Maehara, Tetsuya Kusumoto, Yuji Ichiyoshi, Michihiko Kuwano, Keizo Sugimachi, Expression of multidrug-resistance-associated protein (MRP) and chemosensitivity in human gastric cancer International Journal of Cancer. ,vol. 68, pp. 372- 377 ,(1996) , 10.1002/(SICI)1097-0215(19961104)68:3<372::AID-IJC16>3.0.CO;2-A